Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Nasdaq Real Time Price USD

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)

Compare
4.9500
+0.2300
+(4.87%)
At close: April 17 at 4:00:00 PM EDT
Currency in SGD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Total Revenue
100.7730
100.7730
56.5990
58.5040
Cost of Revenue
64.1680
64.1680
36.6210
35.4470
Gross Profit
36.6050
36.6050
19.9780
23.0570
Operating Expense
1,068.8480
1,068.8480
1,144.4270
541.1240
Operating Income
-1,032.2430
-1,032.2430
-1,124.4490
-518.0670
Net Non Operating Interest Income Expense
-56.5870
-56.5870
-2.0170
-2.7830
Other Income Expense
3.0630
3.0630
39.5650
1.1640
Pretax Income
-1,085.7670
-1,085.7670
-1,087.1710
-519.6860
Earnings from Equity Interest Net of Tax
-33.7880
-33.7880
-7.3450
--
Net Income Common Stockholders
-1,119.5550
-1,119.5550
-1,094.5160
-519.6860
Diluted NI Available to Com Stockholders
-1,119.5550
-1,119.5550
-1,094.5160
-519.6860
Basic EPS
-0.05
--
-0.05
-0.03
Diluted EPS
-0.05
--
-0.05
-0.03
Basic Average Shares
20,500
--
20,500
20,500
Diluted Average Shares
20,500
--
20,500
20,500
Total Operating Income as Reported
-1,068.3290
-1,068.3290
-1,175.7880
-552.7520
Rent Expense Supplemental
46.4030
46.4030
32.0430
24.9920
Total Expenses
1,133.0160
1,133.0160
1,181.0480
576.5710
Net Income from Continuing & Discontinued Operation
-1,119.5550
-1,119.5550
-1,094.5160
-519.6860
Normalized Income
-1,119.5550
-1,119.5550
-1,085.6460
-519.6860
Interest Expense
56.5870
56.5870
2.0170
2.7830
Net Interest Income
-56.5870
-56.5870
-2.0170
-2.7830
EBIT
-1,029.1800
-1,029.1800
-1,085.1540
-516.9030
EBITDA
-994.1210
-994.1210
-1,056.0660
-489.4450
Reconciled Cost of Revenue
56.1030
56.1030
34.6890
33.9270
Reconciled Depreciation
35.0590
35.0590
29.0880
27.4580
Net Income from Continuing Operation Net Minority Interest
-1,119.5550
-1,119.5550
-1,094.5160
-519.6860
Total Unusual Items Excluding Goodwill
--
--
-8.8700
--
Total Unusual Items
--
--
-8.8700
--
Normalized EBITDA
-994.1210
-994.1210
-1,047.1960
-489.4450
12/31/2021 - 4/10/2025

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

KMTS Kestra Medical Technologies, Ltd. Common Stock
24.50
-0.33%
 
ZJYL Jin Medical International Ltd.
0.9400
+1.08%
 
IZAFE-B.ST iZafe Group AB (publ)
0.2590
+4.02%
 
MEDIMI.ST Medimi AB (publ)
0.0036
0.00%
 
S2M.ST S2Medical AB (publ)
0.0134
+16.52%
 
CY9D.F Microbot Medical Inc.
2.2460
+4.76%
 
POCI Precision Optics Corporation, Inc.
3.9500
-1.25%
 
NNNN Anbio Biotechnology Class A Ordinary Shares
6.61
+2.64%
 
RVP Retractable Technologies, Inc.
0.6975
+0.65%
 
STSS Sharps Technology, Inc.
0.0320
+20.75%